Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 775

Results For "ge"

9674 News Found

Juniper Biologics signs exclusive license agreement with Helsinn for infigratinib (INN) for the emerging markets including India
Biotech | May 04, 2022

Juniper Biologics signs exclusive license agreement with Helsinn for infigratinib (INN) for the emerging markets including India

Infigratinib is not FDA-, Health Canada- or Therapeutics Goods Association-approved for any other indication


Foundation S: Sanofi’s new philanthropic spearhead
Sustainability | May 04, 2022

Foundation S: Sanofi’s new philanthropic spearhead

Foundation S will incorporate as its cornerstone initiative the former Sanofi Espoir Foundation’s ‘My Child Matters’ program in childhood cancer


GOQii launches first of its kind one-stop solution for Diabetes care in India
Startup | May 04, 2022

GOQii launches first of its kind one-stop solution for Diabetes care in India

An Integrated programme comprising GOQii device, Glucometer – Contour Plus+1 from Ascensia Diabetes Care India and personalised diabetes coaching


Pfizer sets up global drug development centre in Chennai
News | May 04, 2022

Pfizer sets up global drug development centre in Chennai

The facility is among 12 centres established worldwide, and the first in Asia


Sona Group partners with Mycelium Biotechnology for R&D in Salem
Biotech | May 02, 2022

Sona Group partners with Mycelium Biotechnology for R&D in Salem

As a global mushroom biotechnology group, Mycelium Biotechnology is engaged in mushroom growing, global distribution and offering biotechnology and nutraceutical solutions through global partners


Intravacc signs an exclusive license agreement with Zhifei Lvzhu Biopharmaceutical
Biotech | May 02, 2022

Intravacc signs an exclusive license agreement with Zhifei Lvzhu Biopharmaceutical

Avacc 3 has significant advantages over existing whooping cough vaccines


USFDA concludes inspection of Shilpa Medicare with four observations
News | May 02, 2022

USFDA concludes inspection of Shilpa Medicare with four observations

The inspection was triggered by Shilpa's submission of applications for four ANDA's to seek approval to use this site as an alternate testing laboratory


NHA enlists Pristyn Care as health tech partner for Ayushman Bharat Digital Mission
Healthcare | May 02, 2022

NHA enlists Pristyn Care as health tech partner for Ayushman Bharat Digital Mission

ABDM is a critical integration that leverages an open, interoperable, standards-based digital system that is secure, and maintains confidentiality and privacy of health-related personal information


Xcardia announces first-in-human use of its new Xtractor device
Biotech | May 02, 2022

Xcardia announces first-in-human use of its new Xtractor device

The announcement follows FDA 510(k) clearance of device


NORD announces over US $ 100,000 in grant funding available for rare disease research
Biotech | May 02, 2022

NORD announces over US $ 100,000 in grant funding available for rare disease research

Three RFPs now open for qualified researchers through NORD's Jayne Holtzer rare disease research grants program